Clinical outcomes and predictive factors of immunotherapy efficacy in non-small-cell lung cancer brain metastases: a comparative study

Related articles

1. Brain Radiotherapy Combined with Immune Checkpoint Inhibitors and Chemotherapy as First-Line Treatment for Advanced Non-Small Cell Lung Cancer with Brain Metastases: A Retrospective Study

   This article has 23 authors:

   1. Wenjie Wu
   2. Ting Zhong
   3. Xiaolong Zhou
   4. Weiqiong Chen
   5. Xing Zhang
   6. Huiming Xu
   7. Zian Tang
   8. Wenkai He
   9. Yijian Wang
   10. Gongrang Chen
   11. Yan Wang
   12. Boyu Liu
   13. Yingjie Liu
   14. Yongping Han
   15. Kaili Lu
   16. Yaoheng Wang
   17. Bing Zhang
   18. Lingjun Xiao
   19. Ziyun Du
   20. Quan Liu
   21. Juan Liang
   22. Xiantao Li
   23. Lianxi Song

2. Revisiting the Role of Surgery in Brain Metastatic Small Cell Lung Cancer: Survival Benefit in Selected Patients

   This article has 4 authors:

   1. Ravit Gabay Yehezkely
   2. Ariella R Eisenberg BSc¹
   3. Ido Livneh
   4. Rachel Grossman

3. Systemic Inflammatory Indices as Accessible Biomarkers for Intracranial Outcome and Prognosis in Driver Gene-Negative NSCLC with Brain Metastases Treated with First-Line Chemoimmunotherapy

   This article has 5 authors:

   1. Mengqiu Tang
   2. Peijin Wang
   3. Shiwei Li
   4. Tian Chen
   5. Yang Zhou